secwatch.observer — SEC 8-K summary
======================================

Issuer:     MCKESSON CORP (MCK)
CIK:        0000927653
Form:       8-K
Filed at:   2026-05-07T23:59:59+00:00
Accession:  0000927653-26-000066
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

McKesson Q4 adj EPS $11.69 (+16% YoY); FY2027 guidance $43.80-$44.60
--------------------------------------------------------------------

- Q4 revenue $96.3B (+6%), full-year $403.4B (+12%); GAAP EPS $13.71, adjusted EPS $39.11 (+18% FY).
- FY2027 adjusted EPS guidance $43.80-$44.60 (12-14% growth); reaffirms long-term 13-16% target.
- Board approved $5.0B share repurchase increase (total $7.7B); $2.25B accelerated buyback entered.
- Full-year cash from operations $6.2B, free cash flow $5.4B.
- CEO cites specialty and biopharma services strength; Europe divestiture and Med-Surg separation progressing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/927653/000092765326000066/0000927653-26-000066-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/927653/000092765326000066/mck-20260507.htm
  HTML page:      https://secwatch.observer/filing/0000927653-26-000066

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer